KinoPharma

Kyoto Innovative for Neglected Orphan diseases

Focusing on the research on “kinases”,
KinoPharma aims to develop and provide medicines
for diseases with unmet medical
needs such as viral diseases
and neurodegenerative diseases.

  • All
  • Press Release
  • Information

2018/08/29Press Release

We launched a collaborative research project for exploring new drug development for alzheimer’s disease with National Institutes for Quantum and Radiological Science and Technology.

View the press release (PDF)

2017/09/28Information

Our project "antiviral drug development for Human Papillomavirus(HPV), which causes cervical cancer", was adopted as a grant of the KYOTO Industrial Support Organization 21.

2017/08/24Information

Mr. Kuroishi, CEO,showed the status of our business regarding development of the anti-virus agentat the "IPO Caravan" sponsored by the Mitsubishi UFJ Trust Bank.

2018/08/29Press Release

We launched a collaborative research project for exploring new drug development for alzheimer’s disease with National Institutes for Quantum and Radiological Science and Technology.

View the press release (PDF)

2017/09/28Information

Our project "antiviral drug development for Human Papillomavirus(HPV), which causes cervical cancer", was adopted as a grant of the KYOTO Industrial Support Organization 21.

2017/08/24Information

Mr. Kuroishi, CEO,showed the status of our business regarding development of the anti-virus agentat the "IPO Caravan" sponsored by the Mitsubishi UFJ Trust Bank.

2017/08/04Information

Mr. Kuroishi, CEO, had an oral presentation at the "1st Healthcare Venture Conference KYOTO" held at the Kyoto Research Park.

About KinoPharma

Kinopharma conducts research on and develops first-in-class kinase inhibitors. The company name “KinoPharma” stands “kinome” and “creating novel medicines”.

Business Description

Collaboration with top-notch universities and research institutes in Japan, combined with our know-how and experience on the drug research and development, we make the novel concepts of medicine ,that are difficult for large organizations to tackle, to drugs.

Research and Development

We are actively pursuing research and development of small molecule drugs not only that explore new therapeutic possibilities by the novel concept of medicine, but also that can be taken by anyone in the world who suffers from diseases without excessive treatment cost.